Eng

Genesia Ventures closes USD 75 million fund to invest in Japanese and Southeast Asian startups

KrASIA
更新於 2020年10月26日21:06 • 發布於 2020年10月26日13:06 • Stephanie Pearl Li

Tokyo-based venture capital firm Genesia Ventures announced the final closing of its second fund worth USD 75 million on Monday, which will target Japanese and Southeast Asian startups in the fields of digital transformation and media, among others.

The fund, launched in January last year, had already raised USD 45 million at the time, with a target to reach USD 80 million by the end of September. However, Genesia Ventures was only able to raise USD 75 million, falling just short of its target.

The fund will be used to target early-stage startups in Japan and Southeast Asia. Its most recent investment was in BuyMed in April, a Vietnamese healthcare startup that received USD 2.5 million in a pre-Series A funding from Genesia and Sequoia Capital India’s seed-stage fund Surge.

廣告(請繼續閱讀本文)

Genesia Ventures, founded in 2016, has already invested in 47 seed and early-stage startups in Japan and Southeast Asia from its first fund totaling USD 35 million which was completed in December 2017, according to the statement.

查看原始文章

更多 Eng 相關文章

LG Innotek Shines on Global Stage with Automotive Lighting Innovations
PR Newswire (美通社)
Xinhua Commentary: Chinese economy progressing well in pursuit of 2024 targets
XINHUA
Two In Vitro Studies on Eravacycline (XERAVA®) Presented at IDWeek, Demonstrating Its Sustained and Robust Antimicrobial Activity
PR Newswire (美通社)
Turfan Leads the Way: Electricity Drives Development of Smart Irrigation Demonstration Zone
PR Newswire (美通社)
Sungrow Strengthens Australian Market Presence with 1.7GWh of C&I Energy Storage Partnerships with Raystech and Solar Juice
PR Newswire (美通社)
Hanwha Power Systems signs MOU with TC Energy to accelerate commercialization of sCO2 power generation
PR Newswire (美通社)
Global Times: Neo-Chinese cuisine: How China is reimagining its food heritage
PR Newswire (美通社)
Cambodia targets 70 pct clean energy by 2030: minister
XINHUA
Turfan's Real-Time Power Response System Boosts Regional Tourism
PR Newswire (美通社)
The Global AI Defense Challenge 2024 Announces Winners Across Two Competition Tracks
PR Newswire (美通社)
Olverembatinib Surmounts Ponatinib and Asciminib Resistance and Is Well Tolerated in Patients With CML and Ph+ ALL: New Report in JAMA Oncology
PR Newswire (美通社)
Update: China has half of top 20 science cities: Nature Index
XINHUA
Olverembatinib Surmounts Ponatinib and Asciminib Resistance and Is Well Tolerated in Patients With CML and Ph+ ALL: New Report in JAMA Oncology
PR Newswire (美通社)